The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Chemotherapy for second‐stage Human African trypanosomiasis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, June 2013
|
| DOI | 10.1002/14651858.cd006201.pub3 |
| Pubmed ID | |
| Authors |
Vittoria Lutje, Jorge Seixas, Adrian Kennedy |
| Abstract |
Human African trypanosomiasis, or sleeping sickness, is a painful and protracted disease affecting people in the poorest parts of Africa and is fatal without treatment. Few drugs are currently available for second-stage sleeping sickness, with considerable adverse events and variable efficacy. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 200 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Argentina | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 198 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 40 | 20% |
| Student > Ph. D. Student | 24 | 12% |
| Student > Bachelor | 19 | 10% |
| Researcher | 15 | 8% |
| Other | 10 | 5% |
| Other | 25 | 13% |
| Unknown | 67 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 25% |
| Nursing and Health Professions | 21 | 11% |
| Biochemistry, Genetics and Molecular Biology | 12 | 6% |
| Agricultural and Biological Sciences | 10 | 5% |
| Chemistry | 6 | 3% |
| Other | 27 | 14% |
| Unknown | 74 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2024.
All research outputs
#2,567,856
of 26,589,077 outputs
Outputs from Cochrane database of systematic reviews
#4,979
of 13,247 outputs
Outputs of similar age
#20,578
of 209,802 outputs
Outputs of similar age from Cochrane database of systematic reviews
#109
of 299 outputs
Altmetric has tracked 26,589,077 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,247 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,802 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 299 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.